/Companies

Profound Medical

NASDAQ: PROF

Mississauga · Founded 2015 · 182 employees on LinkedIn · 3 known investors

Find your way into Profound Medical

Each arrow is one introduction. Sign up to fill in the first one.

129 people can intro you to Arun

Ask Art Bailey to introduce you to Arun Menawat

You →Art · together at Novadaq Technologies Inc. →Arun

29 people can intro you to Rashed

Ask Jamie Chen to introduce you to Rashed Dewan

You →Jamie · together at Profound Medical →Rashed

Sign up to find every way you can get introduced to Profound Medical

  • Your email: who you already know at Profound Medical, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Profound Medical team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.

Founders & leadership

AMArun Menawat
Arun MenawatCEOArun Menawat is CEO and Chairman of Profound Medical, a medical technology company developing MRI-guided thermal ultrasound systems for tissue ablation. He previously served as Chairman and CEO of Novadaq Technologies for 13 years, President of Cedara Software, and held executive roles at Tenneco and Hercules; he holds a Ph.D. in Chemical Engineering from the University of Maryland and an Executive MBA from Northwestern University's Kellogg School of Management.
RD
Rashed DewanChief Financial Officer2015–2026Rashed Dewan is a Chief Financial Officer at Profound Medical with experience in financial and business management and holds a California CPA license.
MBMathieu Burtnyk
Mathieu BurtnykChief Operating Officer
TTTom Tamberrino
Tom TamberrinoChief Commercial Officer

Board

JP
Jean-Francois PariseauBoard director
DLDamian Lamb
Damian LambBoard directorCo-Founder, Managing Partner at Genesys Capital
WC
William CurranBoard director
SS
Samira SakhiaBoard director
KGKenneth Galbraith
Kenneth GalbraithCorporate Director2017–2023Investor at Syncona

Investors · 3

Reported raises · per SEC filings

Form D private placements

$877.5K disclosed across 1 round · 2017

▶$877.5KraisedOct 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jean-Francois PariseauDirector
  • Damian LambDirector
  • Arun MenawatExecutive Officer, Director
  • William CurranDirector
  • Samira SakhiaDirector
  • Kenneth GalbraithDirector
  • Rashed DewanExecutive Officer
Offering amount
$877.5K
Amount sold
$877.5K
Sales commissions
$52.6K
Placement agents
CIBC World Markets Corp.
First sale
Sep 2017
Incorporated
Corporation, Ontario, Canada, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Profound Medical do?
Profound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.
Who are Profound Medical's investors?
Profound Medical's investors include CTI Life Sciences Fund L.P., FACIT (Fight Against Cancer Innovation Trust), Genesys Capital.
How much funding has Profound Medical raised?
Profound Medical has disclosed $877.5K raised across 1 round.
Where is Profound Medical headquartered?
Profound Medical is headquartered in Mississauga.